Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$367K Sell
7,616
-296
-4% -$13.8K 0.01% 576
2025
Q4
$375K Buy
7,912
+35
+0.4% +$1.74K 0.01% 1002
2025
Q3
$372K Buy
7,877
+2,634
+50% +$127K 0.01% 1118
2025
Q2
$253K Buy
5,243
+78
+2% +$3.98K 0.01% 1228
2025
Q1
$286K Buy
+5,165
New +$280K 0.01% 987
2020
Q3
Sell
-11,149
Closed -$569K 805
2020
Q2
$569K Buy
+11,149
New +$542K 0.09% 213
2020
Q1
Sell
-4,876
Closed -$245K 440
2019
Q4
$245K Buy
+4,876
New +$228K 0.03% 472

Other funds holding SNY

J.W. Cole Advisors's SNY Position: Q1 2026 in Review

J.W. Cole Advisors reduced its Sanofi (SNY) stake by 3.7% in Q1 2026, selling an estimated $13.8K and leaving 7,616 shares worth $367K. The position accounts for 0.01% of the portfolio, ranked #576.

J.W. Cole Advisors first reported a position in SNY in Q4 2019 and has held it in 7 quarters since. The position peaked at $569K in Q2 2020. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • J.W. Cole Advisors held 7,616 shares of Sanofi worth $367K as of Q1 2026.
  • J.W. Cole Advisors sold 296 Sanofi shares in Q1 2026, an estimated $13.8K.
  • Sanofi made up 0.01% of J.W. Cole Advisors's portfolio in Q1 2026, its #576 holding.
  • J.W. Cole Advisors first reported a position in Sanofi in Q4 2019 and has held it in 7 quarters since.
  • J.W. Cole Advisors's Sanofi position peaked at $569K in Q2 2020.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on J.W. Cole Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.